Impact of the high concentration non-avian high molecular weight hyaluronan on pain medication use among osteoarthritis patients

Real-world impact of the high concentration non-avian high molecular weight hyaluronan on pain medication use among osteoarthritis patients.

Article specifications

This retrospective cohort study was published in 2019 in Journal of Curr Med Res Opin. (IF 2018: 0.99) by American specialists. This study aims to update the prior study results to include only the high concentration non-avian high molecular weight hyaluronan (HMW-HA) injectables using data from recent years.

 

Result

Based on this retrospective cohort study, the high concentration non-avian HMW-HA may offer effective pain alleviation among knee OA patients while reducing prescription pain medications such as steroids, NSAIDs and opioids.